Log In
BCIQ
Print this Print this
 

ACT-902

  Manage Alerts
Collapse Summary General Information
Company Alpha Cancer Technologies Inc.
Description Combination of thapsigargin and recombinant human alpha fetoprotein (AFP)
Molecular Target Alpha fetoprotein (AFP)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid and liquid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today